Corrigendum: The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on copd outcomes (Int J Chron Obstruct Pulmon Dis., (2017), 12, (59–71), 10.2147/COPD.S117196);The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

International Journal of COPD

Volumn 12, Issue , 2017, Pages 59-71

  Bosnic Anticevich, Sinthia ^a   Chrystyn, Henry ^b   Costello, Richard W ^c,d   Dolovich, Myrna B ^e   Fletcher, Monica J ^f   Lavorini, Federico ^g   Rodríguez Roisin, Roberto ^h   Ryan, Dermot ^i,j   Ming, Simon Wan Yau ^b   Price, David B ^b,k  

^a SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^b University of Aberdeen   (Singapore)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

^e MCMASTER UNIVERSITY   (Canada)

^f EDUCATION FOR HEALTH   (United Kingdom)

^g UNIVERSITY OF FLORENCE   (Italy)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ Optimum Patient Care Global   (United Kingdom)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Inhalation technique; Inhaler devices; Matched cohort; Observational

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DRUG COMBINATION;

ADULT; ADVERSE OUTCOME; AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; INHALER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; SEX; SMOKING; ATTITUDE TO HEALTH; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECTS; EQUIPMENT DESIGN; FACTUAL DATABASE; INHALATIONAL DRUG ADMINISTRATION; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEBULIZER; NONLINEAR SYSTEM; ODDS RATIO; PATHOPHYSIOLOGY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SELF CARE; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EQUIPMENT DESIGN; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEBULIZERS AND VAPORIZERS; NONLINEAR DYNAMICS; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SELF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85007545231     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S156325     Document Type: Erratum

References (30)

1. Global Initiative for Chronic Obstructive Lung DG. Pocket Guide to COPD Diagnosis, Management and Prevention. Available from: http://www.goldcopd.it/materiale/2015/GOLD_Pocket_2015.pdf. Accessed July 25, 2016.
2. Newman SP. Inhaler treatment options in COPD. Eur Respir Rev. 2005;14:102–108.
3. Newman SP, Pavia D, Garland N, Clarke SW. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl. 1982;119:57–65.
4. Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331.
5. Chrystyn H. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. Respir Med. 2003;97(2):181–187.
6. Holmes MS, Seheult JN, O’Connell P, et al. An acoustic-based method to detect and quantify the effect of exhalation into a dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2015;28(4):247–253.
7. Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–2401.
8. Arora P, Kumar L, Vohra V, et al. Evaluating the technique of using inhalation device in COPD and bronchial asthma patients. Respir Med. 2014;108(7):992–998.
9. Broeders ME, Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med. 2003;16(2):131–141.
10. Lavorini F, Levy ML, Corrigan C, Crompton G; ADMIT Working Group. The ADMIT series – issues in inhalation therapy. (6) Training tools for inhalation devices. Prim Care Respir J. 2010;19(4):335–341.
11. Melani AS, Bracci LS, Rossi M. Reduced peak inspiratory effort through the diskus((R)) and the turbuhaler((R)) due to mishandling is common in clinical practice. Clin Drug Investig. 2005;25(8):543–549.
12. Price D, Bosnic-Anticevich S, Briggs A, et al; Inhaler Error Steering Committee. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107(1):37–46.
13. van der Palen J, Klein JJ, van Herwaarden CL, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J. 1999;14(5):1034–1037.
14. Yu AP, Guerin A, de Leon DP, et al. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD. Respir Med. 2011;105(12):1861–1871.
15. Chrischilles E, Gilden D, Kubisiak J, Rubenstein L, Shah H. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am J Manag Care. 2002;8(10):902–911.
16. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996;51(1):39–43.
17. Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56.
18. Optimum Patient Care Research Database (OPCRD). Available from: http://optimumpatientcare.org/our-database/. Accessed July 25, 2016.
19. Roche N, Reddel H, Martin R, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014;11(Suppl 2):S99–S104.
20. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Available from: http://www.encepp.eu/. Accessed July 25, 2016.
21. GOLD. Gold Initiative for Chronic Obstructive Lung Disease. Available from: http://www.goldcopd.org/. Accessed July 25, 2016.
22. Price D, Chrystyn H, Kaplan A, et al. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res. 2012;4(4):184–191.
23. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938.
24. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75(1):18–25.
25. Yu AP, Guerin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486–496.
26. Punekar YS, Landis SH, Wurst K, Le H. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care. Respir Res. 2015;16:141.
27. Price D, Bateman ED, Chisholm A, et al. Complementing the randomized controlled trial evidence base. Evolution not revolution.Ann Am Thorac Soc. 2014;11(Suppl 2):S92–S98.
28. Roy A, Battle K, Lurslurchachai L, Halm EA, Wisnivesky JP. Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma. Prim Care Respir J. 2011;20(2):148–154.
29. Broeders ME, Vincken W, Corbetta L; ADMIT Working Group. The ADMIT series – issues in inhalation therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J. 2011;20(3):338–343.
30. Caliskaner AZ, Ozturk C, Ceylan E, et al. The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study. Tuberk Toraks. 2013;61(3):183–192.